Medtronic Cardiac Surgery

Works in Cardiovascular

Medtronic Cardiac Surgery is a clinical trial sponsor. It has 6 active clinical trials with 9,560 planned participants, in Cardiovascular. Since 2021 it has completed 4 trials and stopped 1 early.

Trial track record · since 2021

6Active trials9,560 planned participants
4Completed6 with results posted
1Stopped early20% of finished trials

Pipeline · 6 active trials

StageTrialStatus

Questions about Medtronic Cardiac Surgery

See the rest of this profile

A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.

Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2026-10-29.

Approve Suite is not affiliated with Medtronic Cardiac Surgery.

See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.